Value proposition

Making clinical proteomics 100 times more robust and 10 times faster

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.

We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

proteomics, clinicalproteomics, and LC-MS